Olawande Funmilola Adebayo

Dr. Olawande Funmilola Adebayo

orcid

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
16 June 2021 in Traffic Injury Prevention
Verified
Journal Article
Closed access
FOFadekemi Olufunmilayo Oginni
Fadekemi Olufunmilayo Oginni
BBBabatunde O. Bamgbose
Babatunde O. Bamgbose
OOOluwaseun Caleb Oginni
Oluwaseun Caleb Oginni
OAOlawande Funmilola Adebayo
Olawande Funmilola Adebayo
OOOlayiwola Victor Olorunfemi
Olayiwola Victor Olorunfemi
MKMohammad Abubakar Kaura
Mohammad Abubakar Kaura
To understand how knowledgeable and equipped the law enforcement agents in Nigeria are to enforce the drink-drive law.We conducted a descriptive cross-sectional study of Law Enforcement Agents in f...

30 March 2026 in Diagnostics
Verified
Journal Article
Open access
PDF file
OAOlawande Funmilola Adebayo
Olawande Funmilola Adebayo
DTDada Temilola
Dada Temilola
FOFoluso Owotade
Foluso Owotade
MCManogari Chetty
Manogari Chetty
Some diseases affecting the oral mucosa can be life-threatening and/or associated with life-threatening complications. Conventional diagnostic methods for most oral mucosal diseases are usually employed at a fully established disease state. All these peculiarities usually result in late diagnosis, poor prognosis, poor treatment outcomes, and reduced overall survival rates, hence the need for novel methods for the early detection of these disease conditions. Small extracellular vesicle (sEV)-based diagnosis carries great potential for early diagnosis of oral mucosal diseases, as sEVs reflect the physiological status of their parent cells. sEVs are also widely distributed in body fluids, which helps overcome the problem of inaccessibility in sample or specimen collection in some cases. Furthermore, the composition of sEVs can be used as diagnostic biomarkers for several disease conditions, including oral mucosal diseases. This review critically examines the emerging role of sEVs-derived biomarkers from saliva and blood in the diagnosis of some oral mucosal diseases, such as hand, foot, and mouth disease (HFMD), oral lichen planus (OLP), oral leukoplakia (OL), and oral squamous cell carcinoma (OSCC). It also discusses the need for the validation and standardization of the potential sEV-derived diagnostic biomarkers of these oral mucosal diseases for clinical application.